PL1768673T3 - Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon - Google Patents

Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon

Info

Publication number
PL1768673T3
PL1768673T3 PL05757277T PL05757277T PL1768673T3 PL 1768673 T3 PL1768673 T3 PL 1768673T3 PL 05757277 T PL05757277 T PL 05757277T PL 05757277 T PL05757277 T PL 05757277T PL 1768673 T3 PL1768673 T3 PL 1768673T3
Authority
PL
Poland
Prior art keywords
risperidone
pharmaceutical composition
orally disintegrating
disintegrating pharmaceutical
orally
Prior art date
Application number
PL05757277T
Other languages
English (en)
Inventor
Vesna; Kroselj
Tadeja Rajer
Marija; Rangus
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil D D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D filed Critical Krka Tovarna Zdravil D D
Publication of PL1768673T3 publication Critical patent/PL1768673T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL05757277T 2004-06-15 2005-06-14 Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon PL1768673T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
EP05757277A EP1768673B1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
PL1768673T3 true PL1768673T3 (pl) 2009-01-30

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05757277T PL1768673T3 (pl) 2004-06-15 2005-06-14 Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (pl)
AT (1) ATE402706T1 (pl)
DE (2) DE102004028940A1 (pl)
EA (1) EA010178B1 (pl)
ES (1) ES2311230T3 (pl)
HR (1) HRP20080452T3 (pl)
NO (1) NO20070187L (pl)
PL (1) PL1768673T3 (pl)
PT (1) PT1768673E (pl)
RS (1) RS50609B (pl)
SI (1) SI1768673T1 (pl)
UA (1) UA87692C2 (pl)
WO (1) WO2005123084A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2172793T3 (es) * 1996-06-17 2002-10-01 Janssen Pharmaceutica Nv Formas de dosificacion biconvexas de desintegracion rapida.
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
WO2003009831A1 (fr) * 2001-07-27 2003-02-06 Yamanouchi Pharmaceutical Co., Ltd. Compositions contenant des grains fins a liberation prolongee pour comprimes a desagregation rapide dans la cavite buccale et procede de production associe
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
EP1620075B1 (en) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
EP1768673B1 (en) 2008-07-30
EA200700023A1 (ru) 2007-06-29
EA010178B1 (ru) 2008-06-30
NO20070187L (no) 2007-03-02
ES2311230T3 (es) 2009-02-01
WO2005123084A1 (en) 2005-12-29
ATE402706T1 (de) 2008-08-15
UA87692C2 (ru) 2009-08-10
PT1768673E (pt) 2008-10-21
RS50609B (sr) 2010-06-30
DE102004028940A1 (de) 2006-01-12
HRP20080452T3 (hr) 2008-10-31
DE602005008607D1 (de) 2008-09-11
EP1768673A1 (en) 2007-04-04
SI1768673T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
MX2009002772A (es) Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo.
AP2007003973A0 (en) Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
TW200637614A (en) Bendamustine pharmaceutical compositions
SG153800A1 (en) Pharmaceutical compositions
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
UA90875C2 (ru) Лекарственные формы пролонгированного действия, которые содержат ранолазин
MX343358B (es) Tabletas de acetato de ulipristal.
IL193252A0 (en) N-hydroxyacrylamide compounds
TN2009000362A1 (en) Weekly administration of dipeptidyl peptidase inhibitors
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
ZA200702418B (en) Taste-masking Pharmaceutical compositions
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
GEP20125458B (en) Matrix metalloproteinase inhibitors
NO20070187L (no) Oralt desintegrerende farmasoytisk preparat omfattende risperidon
GB0406378D0 (en) Novel pharmaceutical compositions
TW200738649A (en) Calcilytic compounds
MX2007001953A (es) Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
GB0406380D0 (en) Novel pharmaceutical compositions
TW200730190A (en) New combination to treat liver fibrosis
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
MX2009003755A (es) Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato.
PL380665A1 (pl) Farmaceutyczne kompozycje
MX2009005804A (es) Composicion farmaceutica de memantina.